Dynorphin inhibits NEP activity in R1.1 mouse thymoma cells.
Irena Martin-Kleiner, Tihomir Balog, Tanja Marotti
Index: Cell Biochem. Funct. 26(8) , 916-9, (2008)
Full Text: HTML
Abstract
NEP/CALLA or CD10 is an endopeptidase (E.C. 3.4.24.11) that inactivates numerous neuropeptides, including dynorphin. Dynorphin is an endogenous opioid polypeptide that binds to kappa-opioid receptors with greatest affinity. R1.1 mouse thymoma cells highly express kappa-opioid receptors. In this study, on R1.1 cells, NEP activity was inhibited by kappa-opioid polypeptide dynorphin (10(-8)-10(-6) M) and by thiorphan (2 x 10(-4) M), a known inhibitor of NEP (30 min treatment). NEP inhibition by dynorphin was stronger than by thiorphan. A non-opioid opioid mechanism of action was mostly involved in this inhibition.
Related Compounds
Related Articles:
2014-10-13
[Biomacromolecules 15(10) , 3802-10, (2014)]
2005-05-05
[J. Med. Chem. 48 , 3269-79, (2005)]
2015-01-01
[J. Chromatogr. A. 1421 , 154-61, (2015)]
2011-01-01
[Chem. Biol. 18(12) , 1631-9, (2011)]
2011-01-01
[Eksp. Klin. Farmakol. 74(8) , 37-40, (2011)]